Preclinical Drug Development
The journey of developing a new pharmaceutical drug is complex and time-consuming. It begins with the discovery of a promising compound, which then undergoes a rigorous process of selection and improvement to determine its suitability as a therapeutic treatment.
Through strategic partnerships with leading research institutes and contract research organizations, Cytoxis accesses a wide range of non-animal testing methods, such as advanced cell-based assays, patient-derived tissues, humanized technologies, and intricate computational modeling techniques.
High Throughput screening
High Throughput screening
High Throughput screening
Harnessing the potential of biomarkers identified from patient samples, we pave the way for groundbreaking advancements in treatment strategies.
In vitro Assays
High Throughput screening
High Throughput screening
Utilizing cutting-edge cell-based assays, drug binding and biochemical assays, we conduct high-throughput screening and pathway analysis to evaluate selectivity and drug efficacy against target diseases.
ADME & Pharmacokinetics
High Throughput screening
ADME & Pharmacokinetics
We delve deep into drug absorption, distribution, metabolism, and excretion dynamics, paving the way for optimized pharmacokinetic profiles.
In vivo Efficacy
Customized Studies
ADME & Pharmacokinetics
Employing sophisticated rodent models, including wild-type, transgenic and humanized models, we meticulously assess efficacy in complex physiological contexts, ensuring robust translational insights.
Safety Assessment
Customized Studies
Customized Studies
Employing a holistic approach encompassing both in vitro and in vivo methodologies, we meticulously evaluate the safety profile of candidate compounds and ensuring compliance with regulatory standards and safeguarding patient well-being.
Customized Studies
Customized Studies
Customized Studies
Our network with diverse research institutions enables us to
customize each product and service program to meet your study requirements.